What the results of Wegovy’s longest clinical trial yet show about ...
WEBMay 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
WEBToday, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults...
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ for ...
WEBAug 25, 2023 · The study of 529 patients, funded by drugmaker Novo Nordisk, found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a...
Wegovy approved to lessen heart attack, stroke risk in overweight ...
WEBMar 8, 2024 · The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA...
FDA approves Wegovy to reduce heart attack and stroke risk - NBC News
WEBMar 8, 2024 · The blockbuster weight loss drug Wegovy is now approved to reduce heart disease risk, drugmaker Novo Nordisk said Friday. The Food and Drug Administration has updated the drug's label, saying...
FDA Approves New Drug Treatment for Chronic Weight …
WEBFDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Wegovy shown to cut risk of stroke and heart attacks ... - NBC News
WEBAug 8, 2023 · The popular obesity drug Wegovy cuts the risk of cardiovascular events, such as heart attack and stroke, by 20%, drugmaker Novo Nordisk said Tuesday. The findings are the first to demonstrate...
Wegovy shown to reduce risk of heart attack, stroke in major ... - CNN
WEBAug 8, 2023 · CNN — The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart-related death by 20% in what’s being called a landmark clinical trial in people with cardiovascular...
Obesity drug Wegovy cut risk of serious heart problems by 20%: …
WEBNov 11, 2023 · The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way …
Novo Nordisk Wegovy approved for cutting heart disease risks
WEBMar 8, 2024 · Novo Nordisk’s Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage. The Food and Drug Administration approved Novo Nordisk’s blockbuster ...